Introduction
Quorum sensing (QS) is a mechanism for cell-to-cell communication enabling bacterial cells to co-ordinate their behaviour according to their population density. Each bacterial cell produces quorum sensing signal molecules (QSSMs) which accumulate in their local environment. The concentration of these QSSMs can therefore be viewed as a measure of the cells' population density. The bacterial cells sense the QSSMs in their immediate environment and respond to their accumulation by altering the expression of specific genes so facilitating a change in phenotype. Thus unicellular bacteria are able to act collectively as a community rather than simply as individuals. In general, QSSM production is induced by the presence of QSSMs and this positive feedback allows for rapid switching behaviour between two phenotypes.
The specific phenotypes controlled by QS depend upon the species of bacteria. QS was first discovered in the marine bacterium Vibrio fischeri which becomes luminescent at high cell population densities [1] . Since then, QS has been found to control many other phenotypes including antibiotic production, motility, biofilm maturation, genetic competence and virulence [2, 3] .
Staphylococcus aureus uses QS to regulate reciprocally colonisation and virulence. While its population size is small, S. aureus produces surface proteins that facilitate adherence to host tissues and uptake to host cells which aids immune evasion [2] . As the population grows, a switch to the production of secreted virulence factors occurs, leading to the damage and degradation of the surrounding host cells and tissues, thus actively attacking the host. Since tissue damage will alert host defence systems, such a delayed 'deployment tactic' may allow the infecting bacteria time to reach a sufficient population size to be able to overwhelm the host [4] .
QS does not mediate communication solely within a population of one species of bacteria, however; it is also manifested as cross-species or cross-strain communication. For example, it has been demonstrated that Burkholderia cepacia can sense Pseudomonas aeruginosa QSSMs in a biofilm [5] . Similarly, there is evidence that the P. aeruginosa QSSMs interfere with the QS system of S. aureus [6] , while strains of S. aureus can communicate with one another. Each strain of S. aureus is placed into one of four distinct agr (accessory gene regulator) categories, groups I-IV. The QSSMs from the strains in each group activate the QS systems of other members of the same group, but inhibit the agr systems in the strains from the remaining three agr groups [7] .
It has also been demonstrated that Staphylococcus epidermidis can inhibit S. aureus groups I-III, while group IV S. aureus strains are the only ones capable of interfering with the QS system of S. epidermidis [8, 9] . Such cross-strain or cross-species competition presumably enables the bacteria that invade first to establish their dominance over strains making further attempts at colonisation and infection. Such competition could potentially be used for therapeutic purposes: a non-pathogenic strain could be genetically engineered with a cross group inhibitory QSSM analogue such as that described by McDowell et al. [10] so preventing the expression of exotoxin virulence factors. Given the autoregulatory nature of the QS system, the construction of a strain producing an inhibitory QSSM is likely to be more efficient than simply adding the relevant QSSM. Down-regulation of virulence within the pathogen population would allow the host's immune system an increased chance of eliminating the organism. The emergence of multi-antibiotic resistant S. aureus (including methicillinand vancomycin-resistant S. aureus, MRSA and VRSA respectively) means that understanding the virulence mechanisms employed by this pathogen to cause disease should aid the development of novel therapies, such as that mentioned above, to combat infection through attenuation of virulence.
The agr operon was first discovered in S. aureus [11] but has since been identified in many other Grampositive bacteria, including the pathogens Clostridium botulinum [12] , Clostridium perfringens [13] , Enterococcus faecaelis [14] and Listeria monocytogenes [15] . In S. aureus, the operon consists of two divergent promoters termed P2 and P3. The P3 transcript encodes a regulatory mRNA, RNAIII. Increased levels of RNAIII result in increased translation of secreted virulence factors and repression of surface protein production [16] . RNAIII is essentially the effector of the agr operon, a regulatory molecule that induces the desired agr phenotype. The P2 promoter controls the QS loop that regulates the activity of both promoters (see Figure 1 ), producing the proteins AgrA, AgrB, AgrC and AgrD. AgrB and AgrC are transmembrane proteins, i.e. after translation, these proteins move into the membrane of the S. aureus cell, while AgrD is anchored to the membrane. AgrB The trigger of the loop is the accumulation of AIP in the environment of the cell.
is a membrane associated enzyme which processes the linear AgrD pro-peptide to generate and export out of the cell the active QSSM (i.e., AgrB facilitates the conversion of intracellular AgrD into extracellular QSSM), a cyclic peptide termed the 'autoinducing peptide' (AIP) [17, 18] . The AgrA and AgrC proteins form a signal transduction system called a two-component system (TCS). A TCS consists of a membrane associated receptor protein (here AgrC) and a response regulatory DNA-binding protein inside the cell (AgrA). The receptor detects the QSSM signal (i.e. the AIP binds to AgrC) and communicates this to the response regulator, which then influences the transcription of the target genes (here activated AgrA upregulates the transcription of the agrBDCA operon as well as RNAIII-dependent and RNAIII-independent genes [19] ).
The structural identity of the AIP molecules of the strains within a given group of S. aureus enables a particular strain to activate the QS systems of all others within its group. The structural differences between groups, on the other hand, provide a natural inhibition process: the AIP molecules are sufficiently similar that they will bind to the AgrC receptor proteins of any strain, but if they bind to an AgrC receptor from an opposition group they will not confer the ability to activate the AgrA protein inside the cell, thus effectively blocking the QS loop and potentially forcing the cells into, or maintaining them in, a down-regulated state where the exotoxins are not produced.
AgrA is activated by AgrC via a phosphorylation cascade. In a classical TCS, the receptor autophospho-rylates on detection of the signal and transfers this phosphate to the regulator. The phosphorylated regulator usually has a higher affinity for the relevant DNA binding site(s) (here, P2 and P3). While much work has been done on defining the agr system, a question mark remains over the mechanisms governing this phosphorylation cascade in all strains and species that use agr. It has been shown in laboratory derivatives of S. aureus that AgrC does indeed autophosphorylate [20] , implying that in this case it functions as a classical TCS. However,
given the variety of TCSs in existence in the bacterial kingdom [21] , suggestions that both AgrA and AgrC could be phosphorylated constitutively in [11] and experimental evidence that AgrA can bind the relevant DNA binding site in either its phosphorylated or its unphosphorylated form (though it has a higher affinity in the former case) in [22] open up the possibility that the phosphorylation cascade may vary within and between strains (the variations in agr systems and their functions between species is discussed in [23] ).
Though models of interacting QS systems exist for Gram-negative bacteria (see, for example, [24] or [25] ), equivalent models of Gram-positive systems are lacking. Given the importance of fully understanding the agr operon before it can be exploited for therapeutic gain, we here focus on cross-strain competitive QS with a view to (i) identifying aspects of the agr system which are most influential in inactivating an opposition strain; and (ii) identifying potential experiments and/or behaviour which could be used to determine the AgrC-AgrA phosphorylation cascade in operation in a particular strain of S. aureus (or, likewise, in any other bacteria employing an agr operon). In consideration of these points, we present three models of cross-strain agr competition, each representing one of the three possible phosphorylation cascades in the TCS. These models have been analysed in the single-strain case in [26] , wherein the TCSs are subject to artificial inhibitor AIP molecules. Descriptions of the three models are given below.
• Model I: the classical TCS.
The receptor (transmembrane AgrC) autophosphorylates on detection of the signal (i.e. on binding to an AIP molecule), followed by a phosphotransfer to the response regulator (AgrA). The phosphorylated response regulator has a higher affinity for the promoter sites than its non-phosphorylated counterpart.
• Model II: the response regulator is constitutively phosphorylated by kinases. Model I follows the classical TCS. In Model II AgrA is constitutively phosphorylated and consequently it is dephosphorylated AgrA which takes on the role of activator. In Model III transmembrane AgrC is phosphorylated in the absence of AIP; upon binding to an AIP molecule it transfers this phosphate to the AgrA protein, leaving phosphorylated AgrA as the activator.
In this case detection of the signal results in a phosphotransfer from the response regulator to the receptor. The dephosphorylated response regulator thus serves as the activator in this model.
• Model III: the receptor is constitutively phosphorylated by kinases.
On detection of the signal, the receptor transfers this phosphate to the response regulator. As with Model I, it is then the phosphorylated response regulator that is the activator. cascade has yet to be identified definitively in any agr operon, though experimental evidence that AgrC autophosphorylates [20] and that phosphorylated AgrA has a high binding affinity with the P2 promoter region lends weight to the classical TCS (Model I) in the strains which have been studied. Given the relative ease of testing hypotheses theoretically and the possible variation between strains and species, all three of these models should be examined (moreover, since there must be phosphotransfer between AgrC and AgrA, these three are the only possibilities).
Analysis of the mathematical models in [26] illustrated that the sensitivity of these three different TCSs to inhibition (i.e., the level of treatment required to inactivate the agr operon) via the addition of synthetic inhibitor molecules was highly dependent upon the phosphorylation cascade: Model I was the most robust and Model II the most sensitive. In addition, each model displayed bistable behaviour in response to inhibitor molecule dosage, suggesting that such an approach to inactivate the agr operon may only be successful if the infection is caught sufficiently early, otherwise potentially impractical levels of inhibitor molecules are required.
A natural extension of this is therefore to consider a competing strain (rather than competing molecules). We focus here on three nondimensional parameters that we believe to be of substantial importance in determining the outcome of the competition between two strains, rather than between a strain and inhibitor molecules; these parameters are the relative population sizes and the relative rates of self-activation binding and of inhibitory binding between receptors and AIPs, principally because these are the parameters most easily specified in reality, either through the treatment dosage or through the design of the therapeutic strain. We explore the responses of the models to variations in these three parameters with the aim of finding parameter sets where one strain can be reliably down-regulated. We demonstrate that the system behaviour in response to alteration in the binding rates can be counter-intuitive and that the most reliable parameter to modulate in order to achieve downregulation of an opposition population is the relative population size.
Formulation

Variables and Parameters
In [27] , the agr operon was modelled in the absence of any competition (i.e. neither an opposing strain nor synthetic inhibitor molecules) and a time-dependent asymptotic analysis was performed to highlight the mechanisms involved in each stage of activation of the operon and to derive simpler models which could be used to analyse further various processes. In this study, we formulate a model of two competitive strains of S. De-phosphorylated receptor bound to cognate AIP in Population j Table 1 : Definitions of the variables, with j = 1, 2 and l = 3 − j.
aureus termed Population 1 and Population 2 and in the absence of one of the populations the models reduce to those of [27] . Thus, we focus the description here on the cross-species interaction terms and the reader may refer to [27] for additional model assumptions and derivations. We require variables to represent the amount of mRNA, proteins etc. in two separate populations. We therefore let X 1 (t) and X 2 (t) represent the amount of X in Population 1 and Population 2 respectively. The resulting variables are displayed in Table 1 .
The models necessarily contain a large number of parameters and as a matter of expedience we assume the parameters governing corresponding reactions in the two populations are equal, i.e. the two populations perform all reactions at equal rates. The only exceptions are the parameters representing population sizes and the rates of association and dissociation. It is the AIP structure which determines group specificity and the latter two rates are accordingly the most likely to differ between groups. Definitions of the parameters are given in Table 2 2. Figure 3 illustrates which AIP binding rates and which dissociation rates correspond to either self-activation or cross-inhibition.
We assume that the two populations are in a (well-mixed) spatially homogeneous environment (a spatially structured extension of this model is discussed in Part 2 of this study [28] The dimensional model reads, with j = 1, 2 and l = 3 − j,
As for the single-species model in [26, 27] , we take the default initial conditions to be the naturally downregulated steady states, i.e. the steady-state solutions to (1)-(13) with k = 0 or, equivalently, as λ a → ∞ (these are not the same as the down-regulated steady states caused by suppression from opposition bacteria). Thus,
,
.
Nondimensional model
The variables are nondimensionalised using the same principles used for the single population model in [26] .
The nondimensionalisation of opposition-bound receptors (the only variable to not have a direct match in the single population model) is chosen to simplify the corresponding equation. The nondimensional variables are thus:
and
We define the nondimensional parameters
We refer to these as the ratio of population sizes, self-activation rates and cross-inhibition rates, respectively.
In order to incorporate these ratios into the model, we define the following nondimensional parameters: ,22,12,21] = γ [11, 22, 12, 21] δ M ,
(these also follow directly from [26] ) whereX is the initial condition of X given by (14) for
finally we set
Assuming that protein degradation rates, λ X in (19) , are negligible relative to r (and since δ X = λ X + r), we set all the parameters in (19) to be equal. Thus
(j = 1, 2 and l = 3 − j respectively).
Default parameter values are those adopted in [26] (with the new cross-strain binding and dissociation rates taken to be of the same order as the equivalent cognate rates), namely
where ǫ = m/v, i.e. the ratio of basal transcription to QS-induced transcription; hatted parameters are all O(1) and will be set to unity in the simulations. Detailed explanations of this parameter choice are provided in [26, 27] , alongside a discussion of the consequences of alternative parameter choices. We summarise briefly our reasoning here.
• It is vital that ǫ be small in order that the cells can induce rapidly the QS-associated switch between downand up-regulated states which is known to arise. Similarly (for Model II only), constitutive phosphorylation of AgrA must be sufficiently fast for this to be achieved.
• Signal transduction reactions should occur at a fast rate relative to general reactions such as transcription and translation (examination of the nondimensional definition of k a in (18) shows why this this assumption also results in k a being large).
(a)
Nondimensional parameter Default value ǫ 0.1 • Housekeeping dephosphorylation of AgrA is relatively slow as an efficient cell should be well-equipped to manage with little of this process.
We remark that k S = O(1) was employed in [27] in order to simplify the asymptotic analysis; however, we here return to the biologically-motivated scaling employed in [26, 29] 
Model II only and so the definition of ψ ′ A is given in §2.3.1, though its size is given above in (21) . All hatted parameters and the remaining nondimensional parameters which are not listed in (21) are taken to be O(1),
and in all simulations we set them to unity: the default parameter values are given in Table 3 .
Dropping ′ s, the nondimensional equations for Model I are:
with the initial conditions:
Notice that the equations representing the two populations are not symmetric in terms of the dimensionless parameters because, to incorporate (17) into the system, the nondimensional parameters in (18) are chosen to be dependent upon the dimensional N 1 , β 11 and β 21 , but not upon N 2 , β 22 or β 12 . For this reason, the bifurcation diagrams will not be symmetric about the points where the two populations are equivalent (i.e. N = 1, β A = 1 and β I = 1).
Model II -AgrA is constitutively phosphorylated
Nondimensional model
In the interest of space, the dimensional Models II and III and the details of their nondimensionalisations (which are largely the same as that of Model I) are relegated to the appendix. We present here the nondimensional models only. The nondimensional Model II (dropping ′ 's) is given by (22), (24)- (35) and
The initial conditions which differ from (38) are
The hatted parameters are scaled according to (21).
Model III -AgrC is constitutively phosphorylated
Nondimensional model
The nondimensional Model III is given by (22)- (29), (36), (37) and
The nondimensional initial conditions which differ from (38) are
The hatted parameters are scaled according to (21) (note that primes have been dropped from the derivation details provided in the appendix).
3 Numerical investigations
Preliminaries
When N = β A = β I = 1 the two populations of cells behave identically, i.e. they result in matching levels of regulation and of all corresponding proteins. We look at how altering these three parameters can affect the solutions of the models with a view to identifying properties of the system which should enable one population to downregulate the other. We track the solution curves in response to varying N , β A and β I , focusing primarily on N , β I > 1 and β A < 1, with the expectation that in these regimes Population 1 should be 'stronger' than Population 2, by which we mean in a better position to inactivate Population 2. Mathematically speaking, We will see that five cases emerge from our analyses, each representing a different situation regarding the potential ability of one population to downregulate the other. Given the number of possibilities, to make the qualitative conclusions clearer to the reader, we summarise these in Table 4 groups reach an up-regulated state (Case V) since both groups are equal and large in size, but as we increase N , the first population begins to dominate, and two fold bifurcations emerge giving Case X (this structure being familiar from the single strain models [26, 27, 30] 
Model II
Model II results in slightly different behaviour around N = 1; Figure 5 shows the bifurcation diagrams forP 1 andP 2 (these being the P 1 and P 2 components of the steady state respectively) as we vary N . For this model there exists an interval around N = 1 in which three stable steady states exist (Case Z): either both populations are up-regulated, or either population can downregulate the other; separating each of these is an unstable steady state. The unstable steady states thus delineate a population's ability to fend off the opposition AIP. If N is increased outside of the tristable interval, the system becomes bistable and, if increased further, monostable.
In the bistable region, either population can inactivate the other (Case Y) and in the monostable region, Population 1 necessarily downregulates Population 2 giving Case W (the equivalent but opposite behaviours occur for decreasing N ). The behaviour differs from Model I, which has two bistable regimes (one in N < 1 and the other in N > 1). In Model II these regimes essentially merge, overlapping around N = 1 and forming a tristable region. We saw in [26] that the Model II TCS is the most sensitive of the three TCSs to inhibition and this is further evidence that this is the case for our parameter choice: if Population 2 begins in a more agr -active state than Population 1 (i.e. P 2 (0) > P 1 (0)) then it may be of no consequence that Population 1 is the larger population (within the multistable region only), and Population 2 can overcome Population 1 (i.e. 1 ≥P 2 > 0.5 >P 1 ≥ 0) simply by having more cells active initially. Thus the sensitivity of this particular TCS to inhibition here results in the initial conditions of the system being potentially more influential than the relative population sizes (again, within the multistable region only) because the Population 1 cells can be inhibited quickly by the already active Population 2 cells.
Model III
Qualitatively, Model III behaves in much the same way as Model I: see Figure 6 . As with Model I, we have Cases V, W and X (the last of these representing the bistable regime); thus over the whole range N > 1, either both populations achieve an up-regulated state (for sufficiently small N > 1) or Population 1 inactivates Population 2 (for sufficiently large N > 1). For N < 1, a similar bistable regime occurs which gives the converse behaviour.
Note that with ǫ = 0.1, Population 1 only needs to be around 2.2 times the size of its counterpart to guarantee success, compared with approximately 5.82 times in Model I and 2.04 times for Model II; this is consistent with the relative efficiency of the three TCS cascades to withstand inhibitor therapy demonstrated in [26] , i.e. Model I is the most robust to inhibition and Model II the most sensitive. It is evident that decreasing ǫ increases the range of N over which multi-stability exists for each model; numerical investigations indicate that this is the case also for the remaining analyses performed in this study.
Henceforth, we display only the ǫ = 0.1 solutions.
Relative self-activating binding rate, β A
Model I
We examine how altering the potency of the different AIPs affects the regulation of their respective populations. Figure 7 shows the solution curve of P 2 of Model I with bifurcation parameter β A . Since we fix β 11 (the rate of self-activating binding in Population 1), increasing 1/β A (the ratio of the rate of self-activating binding in Population 1 to that of Population 2) is equivalent to increasing the difference between the self-activating potencies of the two populations' AIPs, so that 1/β A > 1 means Population 1 has a faster self-activating binding rate than Population 2. We see that increasing 1/β A yields cases V, W and X once again as the first population is able to push the second into downregulation, as would be expected.
Model II
As in §3.2, Model II produces different behaviour to Model I, this time for varying β A -see Figure 8 . We now interval Population 1 has a higher self-activation rate than Population 2, the possibility that Population 2 could inactivate Population 1 could be deemed to be somewhat surprising (we would ordinarily anticipate that this would occur for 1/β A < 1).
In Figure 9 , we present a time-dependent solution illustrating how Population 2 could achieve domination when β A = 1/20 (i.e. from the bistable Case Y and when Population 1 has the faster rate of self-activation). Population 2's initial level of activity (P 2 (0)) is taken to be higher than that of Population 1 (P 1 (0)). The first population initially binds to its AIP so quickly that not enough of its AIP reaches the second population, resulting in a higher concentration of free receptors in the second population (see R j ). Because this population begins in a more active state, it can manipulate this situation to build up a bigger AIP supply (see a j ) with which it can not only activate itself but also inhibit the opposition (see P j ). We note that our numerical investigations suggest that it is a requirement that Population 2 begin in a more active state (or at least not significantly lower) than Population 1 (P 2 (0) > P 1 (0)) for it to dominate (P 2 >P 1 ) in this parameter regime, implying that having a faster self-activation rate resulting in AIP being wasted on cognate cells (leaving insufficient amount to downregulate the opposition cells) is not the sole reason for Population 2 dominating: fewer Population 1 cells must also be active initially. Figure 10 illustrates the solution curves for varying β A in Model III. As for Model II, there is an additional branch of solutions which enables the 'weaker' population (that with the slower rate of self-activation) to dominate, giving Cases V, W, X and Y. Notice that here both of the 'usual' fold bifurcations occur for 1/β A > 1 (meaning that Case V also arises for Model III), while for Model II they lie either side of β A = 1. This again illustrates the higher sensitivity of Model II to inhibition compared to Models I and III for our parameter choice: for Model II the difference between the two populations needs to be less pronounced than for either Model I or Model III in order to ensure that one population is dominant. 
Model III
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Figure 9: Time-dependent numerical solution to Model II (equations (22), (24)- (35) and (39)- (41) The extra single-fold solution curve (which makes Cases Y and Z possible) suggests that the cells could in some sense be too efficient for their own good at fighting off other species: producing an AIP which is too potent can be detrimental to their own efforts at becoming the dominant species.
Whilst mathematically interesting, we must bear in mind whether a realistic parameter choice would allow Cases Y and Z to exist. Since we have taken β 11 = β 21 = O(1/ǫ) in Figure 12 (where ǫ = 0.1), the majority of the parameter range illustrated by these bifurcation diagrams has the dimensional β 12 far greater than the dimensional β 11 , meaning that an AIP's ability to bind to opposing strains is greater than its ability to bind to its own strain which would seem somewhat unlikely. In the more biologically realistic regime where this is not the case, both populations simply reach an active state, rendering much of the previous discussion in this section relevant only if engineering a strain for therapeutic purposes, in which case the signal molecule structure could be specified, and therefore, to a certain extent, its binding ability also.
A more biologically realistic investigation into what happens for varying β I , perhaps, is to set the selfactivating binding rate to be larger than the inhibiting binding rates. Such an investigation (performed numer- ically, but results not shown) shows that qualitatively the same bifurcation curves are produced for any value of β 11 with 10 ≤ β 11 ≤ 50 (when ǫ = 0.1). However, for β 11 > 50 there is a switch in the behaviour of the two populations: the bifurcation diagram for P 1 now resembles that of P 2 for 10 ≤ β 11 ≤ 50 and P 2 that of P 1 , i.e Cases V, X, Y and Z all still exist but the roles of the two populations are reversed in all of these, see Figure 13 .
However, this is, again, likely to be irrelevant in practice: the area of the graph where Population 1's inhibiting rate is slower or equal to its activating rate corresponds to β I ≤ 10 where both populations are up-regulated, i.e. if the self-activating abilities are sufficiently high then altering the inhibiting ability has little effect: both populations will still be in a position to upregulate themselves. This switch in roles also occurs for Model III and we discuss this further in §3.4.3. Figure 14 . If N is sufficiently large, the dimensional β 12 does not even need to be larger than the dimensional β 21 to guarantee that the first population will downregulate the second (Case W), i.e. population size is more influential in determining the outcome than the relative binding abilities. 
Model II
We obtain similar bifurcation curves, see Figure 15 , as for Model I in §3.4.1. The main difference is that only the tristable Case Z and bistable Case Y exist for Model II, i.e. given suitable initial conditions, either population can downregulate the other regardless of β I . Consequently, this behaviour exists in a potentially realistic parameter range (where inhibiting binding rates do not differ greatly from self-activation rates) for Model II.
Model III
Model III is qualitatively similar to Models I and II for varying β I , see Figure 16 . Quantitatively the corresponding fold bifurcations lie at values of β I between those of the previous two models (meaning the possible cases are different for Model III), again reflecting the results of [26] which demonstrated that the Model III TCS would be middle of the three in terms of sensitivity to inhibitor therapy.
As for Model I, Case Y (where Population 2 can downregulate Population 1 despite having a lower inhibiting binding ability) occurs only in a range of β I that is unlikely to be biologically relevant (where the inhibitory we here demonstrate these locations. The dot-dash curve illustrates the location of the fold on the single-fold curve (the minimum value of β I at which Case Y arises), the dashed curve that of the lower fold (by this we mean lower in terms of the value of β I at which it occurs, rather than the value ofP 1 orP 2 ) of the hysteretic curve (the minimum value at which Case X can occur) and, finally, the solid curve its upper fold (similarly, the upper fold corresponds to the fold on the hysteretic curve which occurs at the larger value of β I ), the minimum value of β I giving Case W. Where the dot-dash and dashed curves meet, the roles of the two populations in Cases W, X and Y are reversed. itself regardless (given the fact that it has a large self-activating binding rate). While Population 1 also has this fast rate, it will lose enough AIP to the opposition bacteria to make itself the weaker population. In other words, in this scenario it is important to reach an active state before attempting to downregulate the opposition bacteria -see Figure 19 .
Discussion
The agr system is employed by many Gram-positive bacteria, including a number of important pathogens. It has been demonstrated that S. aureus uses the agr operon as a means of communication, with strains able to activate the agr operon of strains from within the same group and inhibit that of other groups. This cross-strain antagonism has therapeutic implications: a non-pathogenic, inhibitory AIP producing strain of S. aureus could be designed to be administered at the site of a staphylococcal infection in order to inhibit the agr system of the infecting strain, inactivating the production of certain virulence factors and allowing the host's immune system an increased chance of eliminating the pathogen. Figure 19 : Time-dependent numerical solution to Model III using the default initial conditions, β 11 = 100, β I = 22 (i.e. in the regime where either both populations will become active or Population 2 will suppress Population 1) and all other parameters from Table 3 (a) (j = 1, 2 and l = 3 − j). Although Population 1 (solid line) has a higher inhibiting binding rate than Population 2 (dashed line), as both populations have a high self-activating binding rate (i.e. because β 11 = 100), the second population will activate itself quicker since the first will lose more of its own AIP through its attempt at inactivating the opposition cells than vice versa; the second population is consequently in a better position to suppress the QS systems of the first. This demonstrates the importance of reaching an active state as quickly as possible: the second population has already begun the process of upregulation before the first population's AIP has made any real progress in binding to the opposition cells.
the other vice versa, the unstable steady state lying between them can be seen to represent both populations attempting to inactivate each other, but the initial conditions of the system will ultimately determine to which stable state the model is drawn. We considered the effects of varying three factors of the two populations, namely their relative sizes, self-activation potencies and inhibitory potencies. If one population is larger or has faster self-activating or inhibiting rates than the other then there exists the possibility that it will downregulate the second strain; however, this could not always be guaranteed. In many situations, the opposite behaviour to what might be anticipated was also possible (Cases Y and Z) and sometimes even when the initial conditions of the populations were identical. We modelled the three different possible cascades of the TCS and in the case of the classical TCS (Model I) we showed that Cases Y and Z arose only in a potentially unrealistic parameter range. In Models II and III (representing alternative TCS cascades), on the other hand, such behaviour could appear in a realistic parameter range.
The mechanistic details of the agr system can lead to significant differences in the behaviour of competing strains and the differences between the models provide plausible approaches to assessing which cascade is in operation in the TCS of the agr operon of a given strain (either of S. aureus or other Gram-positive bacteria).
For instance, if the unexpected behaviour as outlined by Cases Y and Z is impossible to reproduce experimentally then this is an indication that a classical TCS governs the agr operon.
The results for Model II are less clear cut than for the other two systems: for each parameter variation, there was a tristable region around the parameter value which corresponded to the populations having equal 'strength' where either both populations were up-regulated or one dominated over the other; the parameters had to be increased or decreased sufficiently away from 1 to lose this tristable behaviour. Thus the Model II TCS (where AgrA is constitutively phosphorylated) is weaker than the remaining two TCSs in terms of fending off inhibition, with the Model I TCS (the classical TCS) being the most robust. This is also a reflection of the TCS in isolation and not simply as part of the overall signalling system and these results, therefore, are likely to transfer to other operons beyond the agr system and to bacteria employing similar signal transduction systems.
Furthermore, if a TCS cascade has been fully characterised for a specific strain or species, these investigations provide pointers regarding the use of QS for therapeutic purposes which could be investigated experimentally in animal infection models after engineering a specific cross-group inhibitory AIP into a non-pathogenic strain.
For instance, the analyses provide indications on the features and quantities required of a therapeutic strain to ensure that the infecting strain will be down-regulated. The only parameter that guarantees for all three models that the behaviour is as might naively be expected if made sufficiently large or small is N , the ratio of the population sizes, confirming the intuition that this is the key to ensuring therapeutic success through interference with the QS system. On the other hand, the relative rate of inhibitory binding was the least robust of the three parameters studied in terms of outcome and therefore likely to prove a much more precarious target for a 'designer' strain. Concentrating solely on the relative population sizes, however, may not always be wise: administering a sufficiently large population of bacteria (albeit non-pathogenic) to an infection site would not always be practical. In such circumstances, the analyses presented in this work can be drawn upon to guide the design of a strain which is effective with a more feasible population size, for example by carefully specifying the self-activating rate of the new strain. This analysis, therefore, provides early guidance in the development of such a therapy; many more factors (such as the effect of cell growth rate upon the dynamics of the system or the potential persistence of an agr down-regulated infecting strain due to increased colonisation factor production) must also be considered. Furthermore, it will be necessary to consider the consequences of two competing strains utilising different phosphorelays in their TCSs (in this study we have concentrated solely upon the scenario where competing strains employ identical phosphorelays).
QS is not restricted to pathogenesis in bacteria. It is an important cell communication system which is already known to serve a variety of purposes in an increasing number of bacteria and the likelihood is that, as the study of QS systems continues, numerous other functions will be discovered. Many of these will be of interest due to the benefits which they can bestow, rather than because of the harm which they can cause. For instance, the discovery of the agr operon in the clostridial species [12, 13, 31] may yield a link between QS and the production of biofuels by bacteria such as Clostridium acetobutylicum which can be exploited for environmental and economic gain. Analyses such as those presented here (though focusing on mutually activating systems which could cause the premature upregulation of a particular strain rather than its inactivation) should therefore assist in the acceleration of such processes. The dimensional equations which change from (1)- (13) in Model II are (2), (12) and (13) . Instead, Model II has
A.1.2 Nondimensionalisation
We employ the same nondimensionalisation as for Model I, i.e. (15)- (20), and define the additional parameter:
A.2 Model III -AgrC is constitutively phosphorylated
A.2.1 Dimensional model
The dimensional equations which vary from (1)- (13) for Model III are
additional variables being required for this version of the agr model (see Table 1 for definitions of the various AIP-bound receptors and [26, 29] for more details).
The initial conditions which differ from (14) are
A.2.2 Nondimensionalisations
For Model III, as a result of the additional variables, we cannot simply adopt all the same nondimensionalisations as previously. The variable nondimensionalisations which change from (15) and (16) are thus a ′ j = β [11, 22] 
R P a l j ′ = β [22, 11] φbN l κm β [21, 12] 
The nondimensional parameters which change from (17)- (20) for Model III are λ ′ X = δ X δ M = λ for X = A j , T j , R j , S j , R P j , R P aj j , R P a l j , A P j ,
whereX is the initial condition of X given by (14) and (63) for X = A 1 , T 1 , R P 1 , S 1 .
B Numerical investigations
B.1 Relative cross-inhibition binding rate, β I
B.1.1 Model I
We here present some time-dependent solutions illustrating the various possible behaviours when β I = 180 for Model I. Remember that this parameter choice enables either population to inactivate the other (Case Y from Table 4 ).
In Figure 20 we take the default initial conditions given by (38) for the first population and those for the second to be zero for all variables. We see how this initial advantage allows the first population to maintain the second in a down-regulated state, whilst upregulating itself. A slightly surprising result here is that the number of opposition-bound receptor in the first population is in fact higher than that of the second despite the fact that the first population is the active one (see R a l j ); this is because the number of unbound transmembrane AgrC is also much higher in the first population, so there is more available to attach to either AIP. A better comparison than between R 1 a2 and R 2 a1 is to compare the ratios R P a1 1 /R 1 a2 and R P a2 2 /R 2 a1 , i.e. self-bound receptor to opposition-bound receptor. The final graph of Figure 20 shows that this is indeed higher for Population 1. Figure 21 represents the solutions when we take the standard initial conditions, given by (38), for both populations. We see that despite the fact that they start in equivalent states with the exception that Population 1 has the advantage that the dimensional β 12 > β 21 (so it has a faster rate of cross-species binding), the second population succeeds in forcing the first into an inactive state, achieving upregulation (P 2 is much larger than P 1 andP 2 is close to unity). A possible interpretation of this is that β 12 is so large that initially any available AIP from the first population binds to receptors of the second, resulting in more free AIP from the second population in the initial stages, allowing Population 2 to maximise its advantage and become up-regulated.
Finally, in Figure 22 we have taken the standard initial conditions for all variables except P 1 (0) which we have increased to P 1 (0) = 0.1. This time, the solutions initially tend towards an inactive Population 1 and active Population 2. However, the slight extra strength of the first population gained through increasing its initial it to achieve upregulation, simultaneously suppressing Population 2 (dashed lines).
level of activity enables it to produce enough AIP eventually to win the battle between the two populations and achieve a much higher level of up-regulation:P 1 >>P 2 (on [0 1]).
